Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verrica Pharmaceuticals (VRCA) Other Non Operating Income (2022 - 2025)

Verrica Pharmaceuticals (VRCA) has 4 years of Other Non Operating Income data on record, last reported at -$2000.0 in Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 99.92% year-over-year to -$2000.0; the TTM value through Dec 2025 reached -$3000.0, up 99.89%, while the annual FY2025 figure was -$3000.0, 99.89% up from the prior year.
  • Other Non Operating Income reached -$2000.0 in Q4 2025 per VRCA's latest filing, up from -$254000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $254000.0 in Q1 2025 and bottomed at -$2.6 million in Q4 2024.
  • Average Other Non Operating Income over 4 years is -$398400.0, with a median of -$1500.0 recorded in 2024.
  • The widest YoY moves for Other Non Operating Income: up 2409.09% in 2025, down 25300.0% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at -$1.4 million in 2022, then soared by 103.53% to $49000.0 in 2023, then plummeted by 5479.59% to -$2.6 million in 2024, then skyrocketed by 99.92% to -$2000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were -$2000.0 in Q4 2025, -$254000.0 in Q3 2025, and -$1000.0 in Q2 2025.